Gedea Biotech granted European Patent for its treatment pHyph for women with vaginal fungal infections
PRESS RELEASE Lund, Sweden, October 25, 2021. Patent now valid in two of the world’s largest markets, Europe and USA until 2037 Swedish women’s health company Gedea Biotech today announced that the company has been granted a patent from the European Patent Office, covering the treatment of fungal…
